ViewRay Gets 510(k) Clearance for Its MRIdian MRI-Guided Radiation Therapy Software

ViewRay has received the FDA’s 510(k) clearance for its next generation of magnetic resonance imaging (MRI)-guided radiation therapy software.

MRIdian A3i includes new features to streamline on-table adaptive workflow and reduce treatment times, the Cleveland, Ohio-based company said.

The new version of the software also includes a new brain treatment package expanding its clinical utility into cranial stereotactic radiosurgery and stereotactic radiation therapy.